Occurrence of cytomegalovirus hepatitis in liver transplant patients

O. Bronsther, L. Makowka, R. Jaffe, A. J. Demetris, M. K. Breinig, M. Ho, C. O. Esquivel, R. D. Gordon, S. Iwatsuki, A. Tzakis, J. W. Marsh, V. Mazzaferro, D. Van Thiel, T. E. Starzl

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The differential diagnosis of liver dysfunction after orthotopic liver transplantation can be difficult. Cytomegalovirus (CMV) hepatitis is one possibility. This report reviews our experience with 17 cases of pathologically proven CMV hepatitis following liver transplantation and demonstrates the need for percutaneous liver biopsies to establish the diagnosis. There were seven pediatric patients (ages 2-11 years, five males, two females) and ten adults patients (ages 17-53 years, eigth males, two females). The most common symptoms were prolonged fever (15 patients, with a mean duration of 22 ± 5.5 days), elevation in total bilirubin (14 patients), and elevation in liver enzymes (15 patients); all symptoms were also found in rejection. Leukopenia and thrombocytopenia, reported to frequently occur with CMV infection, were found in only three and five patients, respectively. Twelve patients with the above symptoms underwent percutaneous biopsy on one or more occasions to differentiate CMV hepatitis from rejection. The diagnosis was made at retransplantations in five patients. CMV hepatitis followed treatment for acute rejections in 14 patients and occurred without additional immunosuppression in three patients. All patients were maintained on cyclosporine and prednisone. Acute rejection episodes were treated with a 5-day tapering dose of steroids (17 courses in 12 patients), OKT3 monoclonal antibody [Ortho (4 patients)] antithymocyte globulin [Upjohn (2 patients)], and azathioprine (1 patient). CMV was isolated from urine (nine patients), blood (nine patients), throat (seven patients), lungs (two patients), and other organs (two patients). CMV was cultured from the liver biopsy specimens in five of the seven attempts in pediatric patients. When the diagnosis was confirmed in the absence of rejection, immunosuppression was routinely lowered. When rejection occurred concomitantly with CMV hepatitis, therapy had to be individualized. Retrospectively, three patients treated for rejection were noted at retransplantation to have only CMV hepatitis, and all three patients died. A high index of suspicion and the judicious use of liver biopsies is essentiall in order to differentiate CMV hepatitis from other causes of posttransplant liver dysfunction.

Original languageEnglish
Pages (from-to)423-434
Number of pages12
JournalJournal of Medical Virology
Volume24
Issue number4
Publication statusPublished - 1988

Fingerprint

Cytomegalovirus
Hepatitis
Transplants
Liver
Biopsy
Liver Transplantation
Immunosuppression
Liver Diseases
Pediatrics
Muromonab-CD3
Antilymphocyte Serum

ASJC Scopus subject areas

  • Virology

Cite this

Bronsther, O., Makowka, L., Jaffe, R., Demetris, A. J., Breinig, M. K., Ho, M., ... Starzl, T. E. (1988). Occurrence of cytomegalovirus hepatitis in liver transplant patients. Journal of Medical Virology, 24(4), 423-434.

Occurrence of cytomegalovirus hepatitis in liver transplant patients. / Bronsther, O.; Makowka, L.; Jaffe, R.; Demetris, A. J.; Breinig, M. K.; Ho, M.; Esquivel, C. O.; Gordon, R. D.; Iwatsuki, S.; Tzakis, A.; Marsh, J. W.; Mazzaferro, V.; Van Thiel, D.; Starzl, T. E.

In: Journal of Medical Virology, Vol. 24, No. 4, 1988, p. 423-434.

Research output: Contribution to journalArticle

Bronsther, O, Makowka, L, Jaffe, R, Demetris, AJ, Breinig, MK, Ho, M, Esquivel, CO, Gordon, RD, Iwatsuki, S, Tzakis, A, Marsh, JW, Mazzaferro, V, Van Thiel, D & Starzl, TE 1988, 'Occurrence of cytomegalovirus hepatitis in liver transplant patients', Journal of Medical Virology, vol. 24, no. 4, pp. 423-434.
Bronsther O, Makowka L, Jaffe R, Demetris AJ, Breinig MK, Ho M et al. Occurrence of cytomegalovirus hepatitis in liver transplant patients. Journal of Medical Virology. 1988;24(4):423-434.
Bronsther, O. ; Makowka, L. ; Jaffe, R. ; Demetris, A. J. ; Breinig, M. K. ; Ho, M. ; Esquivel, C. O. ; Gordon, R. D. ; Iwatsuki, S. ; Tzakis, A. ; Marsh, J. W. ; Mazzaferro, V. ; Van Thiel, D. ; Starzl, T. E. / Occurrence of cytomegalovirus hepatitis in liver transplant patients. In: Journal of Medical Virology. 1988 ; Vol. 24, No. 4. pp. 423-434.
@article{a549966a684941799e09236ea801a0f1,
title = "Occurrence of cytomegalovirus hepatitis in liver transplant patients",
abstract = "The differential diagnosis of liver dysfunction after orthotopic liver transplantation can be difficult. Cytomegalovirus (CMV) hepatitis is one possibility. This report reviews our experience with 17 cases of pathologically proven CMV hepatitis following liver transplantation and demonstrates the need for percutaneous liver biopsies to establish the diagnosis. There were seven pediatric patients (ages 2-11 years, five males, two females) and ten adults patients (ages 17-53 years, eigth males, two females). The most common symptoms were prolonged fever (15 patients, with a mean duration of 22 ± 5.5 days), elevation in total bilirubin (14 patients), and elevation in liver enzymes (15 patients); all symptoms were also found in rejection. Leukopenia and thrombocytopenia, reported to frequently occur with CMV infection, were found in only three and five patients, respectively. Twelve patients with the above symptoms underwent percutaneous biopsy on one or more occasions to differentiate CMV hepatitis from rejection. The diagnosis was made at retransplantations in five patients. CMV hepatitis followed treatment for acute rejections in 14 patients and occurred without additional immunosuppression in three patients. All patients were maintained on cyclosporine and prednisone. Acute rejection episodes were treated with a 5-day tapering dose of steroids (17 courses in 12 patients), OKT3 monoclonal antibody [Ortho (4 patients)] antithymocyte globulin [Upjohn (2 patients)], and azathioprine (1 patient). CMV was isolated from urine (nine patients), blood (nine patients), throat (seven patients), lungs (two patients), and other organs (two patients). CMV was cultured from the liver biopsy specimens in five of the seven attempts in pediatric patients. When the diagnosis was confirmed in the absence of rejection, immunosuppression was routinely lowered. When rejection occurred concomitantly with CMV hepatitis, therapy had to be individualized. Retrospectively, three patients treated for rejection were noted at retransplantation to have only CMV hepatitis, and all three patients died. A high index of suspicion and the judicious use of liver biopsies is essentiall in order to differentiate CMV hepatitis from other causes of posttransplant liver dysfunction.",
author = "O. Bronsther and L. Makowka and R. Jaffe and Demetris, {A. J.} and Breinig, {M. K.} and M. Ho and Esquivel, {C. O.} and Gordon, {R. D.} and S. Iwatsuki and A. Tzakis and Marsh, {J. W.} and V. Mazzaferro and {Van Thiel}, D. and Starzl, {T. E.}",
year = "1988",
language = "English",
volume = "24",
pages = "423--434",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Occurrence of cytomegalovirus hepatitis in liver transplant patients

AU - Bronsther, O.

AU - Makowka, L.

AU - Jaffe, R.

AU - Demetris, A. J.

AU - Breinig, M. K.

AU - Ho, M.

AU - Esquivel, C. O.

AU - Gordon, R. D.

AU - Iwatsuki, S.

AU - Tzakis, A.

AU - Marsh, J. W.

AU - Mazzaferro, V.

AU - Van Thiel, D.

AU - Starzl, T. E.

PY - 1988

Y1 - 1988

N2 - The differential diagnosis of liver dysfunction after orthotopic liver transplantation can be difficult. Cytomegalovirus (CMV) hepatitis is one possibility. This report reviews our experience with 17 cases of pathologically proven CMV hepatitis following liver transplantation and demonstrates the need for percutaneous liver biopsies to establish the diagnosis. There were seven pediatric patients (ages 2-11 years, five males, two females) and ten adults patients (ages 17-53 years, eigth males, two females). The most common symptoms were prolonged fever (15 patients, with a mean duration of 22 ± 5.5 days), elevation in total bilirubin (14 patients), and elevation in liver enzymes (15 patients); all symptoms were also found in rejection. Leukopenia and thrombocytopenia, reported to frequently occur with CMV infection, were found in only three and five patients, respectively. Twelve patients with the above symptoms underwent percutaneous biopsy on one or more occasions to differentiate CMV hepatitis from rejection. The diagnosis was made at retransplantations in five patients. CMV hepatitis followed treatment for acute rejections in 14 patients and occurred without additional immunosuppression in three patients. All patients were maintained on cyclosporine and prednisone. Acute rejection episodes were treated with a 5-day tapering dose of steroids (17 courses in 12 patients), OKT3 monoclonal antibody [Ortho (4 patients)] antithymocyte globulin [Upjohn (2 patients)], and azathioprine (1 patient). CMV was isolated from urine (nine patients), blood (nine patients), throat (seven patients), lungs (two patients), and other organs (two patients). CMV was cultured from the liver biopsy specimens in five of the seven attempts in pediatric patients. When the diagnosis was confirmed in the absence of rejection, immunosuppression was routinely lowered. When rejection occurred concomitantly with CMV hepatitis, therapy had to be individualized. Retrospectively, three patients treated for rejection were noted at retransplantation to have only CMV hepatitis, and all three patients died. A high index of suspicion and the judicious use of liver biopsies is essentiall in order to differentiate CMV hepatitis from other causes of posttransplant liver dysfunction.

AB - The differential diagnosis of liver dysfunction after orthotopic liver transplantation can be difficult. Cytomegalovirus (CMV) hepatitis is one possibility. This report reviews our experience with 17 cases of pathologically proven CMV hepatitis following liver transplantation and demonstrates the need for percutaneous liver biopsies to establish the diagnosis. There were seven pediatric patients (ages 2-11 years, five males, two females) and ten adults patients (ages 17-53 years, eigth males, two females). The most common symptoms were prolonged fever (15 patients, with a mean duration of 22 ± 5.5 days), elevation in total bilirubin (14 patients), and elevation in liver enzymes (15 patients); all symptoms were also found in rejection. Leukopenia and thrombocytopenia, reported to frequently occur with CMV infection, were found in only three and five patients, respectively. Twelve patients with the above symptoms underwent percutaneous biopsy on one or more occasions to differentiate CMV hepatitis from rejection. The diagnosis was made at retransplantations in five patients. CMV hepatitis followed treatment for acute rejections in 14 patients and occurred without additional immunosuppression in three patients. All patients were maintained on cyclosporine and prednisone. Acute rejection episodes were treated with a 5-day tapering dose of steroids (17 courses in 12 patients), OKT3 monoclonal antibody [Ortho (4 patients)] antithymocyte globulin [Upjohn (2 patients)], and azathioprine (1 patient). CMV was isolated from urine (nine patients), blood (nine patients), throat (seven patients), lungs (two patients), and other organs (two patients). CMV was cultured from the liver biopsy specimens in five of the seven attempts in pediatric patients. When the diagnosis was confirmed in the absence of rejection, immunosuppression was routinely lowered. When rejection occurred concomitantly with CMV hepatitis, therapy had to be individualized. Retrospectively, three patients treated for rejection were noted at retransplantation to have only CMV hepatitis, and all three patients died. A high index of suspicion and the judicious use of liver biopsies is essentiall in order to differentiate CMV hepatitis from other causes of posttransplant liver dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0023889346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023889346&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 423

EP - 434

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 4

ER -